{
  "meta": {
    "title": "Aromatic_Amino_Acids_And_Their_Metabolic_Products",
    "url": "https://brainandscalpel.vercel.app/aromatic-amino-acids-and-their-metabolic-products-965c6c33.html",
    "scrapedAt": "2025-11-30T11:11:35.833Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">FIGLU</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Xanthurenic acid</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Methylmalonic acid</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">5-HIAA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is elevated in pyridoxal phosphate deficiency?</span></p>",
      "unique_key": "DT1211348",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211348,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Pyridoxal phosphate (PLP), the active form of vitamin B6, is a required coenzyme for <strong>kynureninase</strong>, an enzyme in the tryptophan degradation pathway. In PLP deficiency, the pathway is blocked, leading to accumulation and urinary excretion of <strong>xanthurenic acid</strong> after tryptophan load.</p>\n<p><strong>Tryptophan metabolism -</strong></p>\n<ul>\n<li>Tryptophan is degraded to amphibolic intermediates via the&nbsp;<strong>kynurenine-anthranilate pathway.</strong></li>\n<li>Tryptophan 2,3-dioxygenase opens the indole ring, incorporates molecular oxygen, and forms N-formylkynurenine.</li>\n<li>Hydrolytic removal of the formyl group of N-formylkynurenine, catalysed by kynurenine formylase, produces kynurenine.</li>\n<li>Since&nbsp;<strong>kynureninase requires pyridoxal phosphate</strong>, excretion of xanthurenate in response to a tryptophan load is diagnostic of vitamin B6 deficiency.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811df1ff7b0-432a-4a78-802f-61a0fe6adfc8.png\"></li>\n<li>5-HIAA is elevated in carcinoid syndrome <strong>(Option D ruled out)</strong></li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Xanthurenic acid is elevated in vitamin B6 deficiency, especially after a tryptophan load.</li>\n<li>PLP is essential for tryptophan metabolism via the kynurenine pathway.<strong><br /> <br /> </strong></li>\n</ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Tryptophan</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Threonine</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosine</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Lysine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Dopamine is synthesized from: </span></p>",
      "unique_key": "DT1211352",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211352,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Dopamine is a catecholamine synthesised from <strong>tyrosine</strong>, a non-essential aromatic amino acid.</p>\n<ul>\n<li>The conversion involves two key enzymatic steps: hydroxylation of tyrosine to <strong>DOPA</strong> (by tyrosine hydroxylase) and decarboxylation of DOPA to <strong>dopamine</strong> by <strong>DOPA decarboxylase</strong>, which is a <strong>pyridoxal phosphate (PLP)</strong>-dependent enzyme.</li>\n<li>Tyrosine is responsible for the synthesis of -\n<ul>\n<li>Melanin</li>\n<li>Thyroxine hormones (T4 &amp; T3)</li>\n<li>Catecholamines (Dopamine, Epinephrine, Norepinephrine)</li>\n</ul>\n</li>\n<li><strong>Dopamine synthesis pathway</strong>:\n<ol>\n<li><strong>Tyrosine &rarr; DOPA</strong> (via <strong>tyrosine hydroxylase</strong>)</li>\n<li><strong>DOPA &rarr; Dopamine</strong> (via <strong>DOPA decarboxylase</strong>, requires PLP)</li>\n</ol>\n</li>\n<li>This pathway occurs in <strong>neuronal and adrenal medullary cells</strong>.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811f75b49a9-8102-4512-9742-d3c125d48eef.png\"></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Tryptophan (Option A): </strong>Precursor for <strong>serotonin</strong>, <strong>melatonin</strong>, and <strong>niacin</strong>, not dopamine.</p>\n<p><strong>Threonine (Option B):</strong> Degraded to <strong>propionyl-CoA</strong> or <strong>glycine</strong> - not involved in catecholamine synthesis.</p>\n<p><strong>Lysine (Option D): </strong>A ketogenic amino acid involved in <strong>carnitine</strong> biosynthesis, unrelated to dopamine.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Tyrosine is the precursor of dopamine</strong>, via DOPA as an intermediate.</li>\n<li><strong>DOPA decarboxylase</strong> requires <strong>vitamin B6 (PLP)</strong> for activity.</li>\n</ul>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Replacement of the defective enzyme</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Replacement of the deficient product</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Limiting the substrate for deficient enzyme</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Giving the missing amino acid by diet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In Phenylketonuria the main aim of first line therapy is:</span></p>",
      "unique_key": "DT1211355",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211355,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The primary therapeutic goal in <strong>Phenylketonuria (PKU)</strong> is to <strong>restrict phenylalanine intake</strong> through diet. This limits the accumulation of <strong>phenylalanine</strong>, the <strong>substrate</strong> for the deficient enzyme <strong>phenylalanine hydroxylase</strong>, and prevents neurotoxic effects such as <strong>mental retardation</strong>.</p>\r\n<p><strong>Phenylketonuria</strong>:-</p>\r\n<ul>\r\n<li><strong>Phenylketonuria (PKU)</strong> is an <strong>autosomal recessive disorder.</strong> Hyperphenylalaninemias arise from defects in -\r\n<ul>\r\n<li><strong>Phenylalanine hydroxylase</strong> (type I, classic phenylketonuria (PKU), frequency 1 in 10,000 births)</li>\r\n<li><strong>Dihydrobiopterin reductase</strong>(type II and III)</li>\r\n<li><strong>Dihydrobiopterin biosynthesis</strong>(type IV and V)</li>\r\n</ul>\r\n</li>\r\n<li>Alternative catabolites are excreted. A diet low in phenylalanine can prevent the mental retardation of PKU.</li>\r\n<li>DNA probes facilitate prenatal diagnosis of defects in phenylalanine hydroxylase or dihydrobiopterin reductase.</li>\r\n<li>Deficiency leads to <strong>hyperphenylalaninemia</strong> and <strong>accumulation of phenyl ketones</strong>, causing:\r\n<ul>\r\n<li>Mental retardation</li>\r\n<li>Seizures</li>\r\n<li>Hypopigmentation</li>\r\n</ul>\r\n</li>\r\n<li><strong>Treatment of Classical PKU:</strong></li>\r\n<li>A low-phenylalanine diet</li>\r\n<li>Administration of large neutral amino acids may help reduce Phe transport into the brain.</li>\r\n<li><strong>Tetrahydrobiopterin (BH4)</strong> supplementation in responsive cases</li>\r\n<li><strong>Screening:</strong></li>\r\n<li>Tandem mass spectrometry is the standard method</li>\r\n<li>Urine ferric chloride test (FeCl<sub>3</sub>) is an older screening tool (green colour with phenylpyruvate)</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Replacement of the defective enzyme (Option A): </strong>Enzyme replacement is not used in PKU. The issue is addressed through dietary management.</p>\r\n<p><strong>Replacement of the deficient product (Option B): </strong>Tyrosine (the product of PAH) may be supplemented, but this is <strong>not the primary goal</strong> of therapy.</p>\r\n<p><strong>Giving the missing amino acid by diet (Option D): </strong>Tyrosine may become conditionally essential in PKU, but the main strategy is to <strong>restrict phenylalanine</strong>.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Dietary phenylalanine restriction</strong> is the cornerstone of PKU management to prevent cognitive deficits.</li>\r\n<li><strong>Phenylalanine hydroxylase deficiency</strong> diverts phenylalanine to toxic metabolites.<br /> </li>\r\n</ul>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylketonuria</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Alkaptonuria</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosinemia type 2</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Argininosuccinic aciduria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">: A 40-year-old woman presents with progressive palmoplantar pigmentation. X-ray spine shows calcification of IV disk. On adding Benedict's reagent to urine, it gives a greenish brown precipitate and a blue-black supernatant fluid. What is the diagnosis?</span></p>",
      "unique_key": "DT1211362",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211362,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The classic triad of <strong>darkening urine on standing</strong>, <strong>ochronosis (bluish-black pigmentation of connective tissues)</strong>, and <strong>calcification of intervertebral discs</strong> with <strong>positive Benedict's test</strong> suggests <strong>alkaptonuria</strong>, caused by <strong>homogentisate oxidase deficiency</strong>.</p>\n<p><strong>Alkaptonuria:</strong></p>\n<ul>\n<li>It is an <strong>autosomal recessive</strong>inborn error of metabolism.</li>\n<li><strong>Biochemical defect - Homogentisate Oxidase deficiency</strong>leads to accumulation of Homogentisic Acid (Homogentisate), which polymerises to form Alkapton bodies.</li>\n<li><strong>Clinical presentation -</strong>\n<ul>\n<li>Normal Life till the 3rd or 4th decade.</li>\n<li><strong>Urine darkens on exposure to air</strong>is the only manifestation in children.</li>\n<li>In adults, <strong>Ochronosis</strong>: Alkapton bodies in intervertebral disk, cartilage of nose, pinna, etc.</li>\n<li>No mental retardation</li>\n</ul>\n</li>\n<li><strong>Laboratory Diagnosis -</strong>\n<ul>\n<li>Alkalization increases the darkening of urine.</li>\n<li>Benedicts test positive in urine because homogentisic acid is a reducing agent.</li>\n<li>Ferric Chloride test positive.</li>\n<li>Silver Nitrate Test positive.</li>\n</ul>\n</li>\n<li><strong>Treatment</strong>-\n<ul>\n<li>Mainly <strong>symptomatic</strong></li>\n<li>Avoid a high-protein diet (rich in phenylalanine &amp; tyrosine)</li>\n<li>Vitamin C may slow ochronosis progression</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081194a58c46-92dc-4bb4-b9f8-733b96aa4ef7.png\"></li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Phenylketonuria (Option A): </strong>PAH deficiency; presents with mental retardation, fair complexion, and musty odour- not ochronosis or positive Benedict's. Tyrosine becomes essential; diagnosis via tandem MS in newborn screening.</p>\n<p><strong>Tyrosinemia type 2 (Option C): </strong>Tyrosine aminotransferase deficiency; presents with eye lesions (keratitis), skin lesions (painful palmoplantar hyperkeratosis), and intellectual disability- not intervertebral calcification.</p>\n<p><strong>Argininosuccinic aciduria (Option D): </strong>Urea cycle disorder; presents with hyperammonemia, vomiting, and lethargy in infancy- no dark urine or connective tissue pigmentation.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Alkaptonuria</strong> presents with ochronosis, darkening urine, and intervertebral disc calcification.</li>\n<li>It is due to <strong>homogentisate oxidase deficiency</strong>, leading to homogentisic acid accumulation.</li>\n</ul>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Benedict test</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">FeCl3 Test</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">FIGLU test</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Turbidometry</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Screening test for phenylketonuria from urine used for newborn infants is</span></p>",
      "unique_key": "DT1211365",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211365,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>The FeCl<sub>3</sub> test is a classic urine screening test used to detect phenylpyruvate in the urine of infants suspected of having <strong>phenylketonuria (PKU)</strong>. A green colour indicates the presence of phenylpyruvate, a byproduct of excess phenylalanine metabolism.</p>\r\n<ul>\r\n<li><strong>Phenylketonuria (PKU)</strong> is caused by <strong>phenylalanine hydroxylase (PAH)</strong></li>\r\n<li>Leads to the accumulation of <strong>phenylalanine</strong> and its transaminated product <strong>phenylpyruvate</strong>.</li>\r\n<li><strong>FeCl3 (Ferric chloride) test</strong>:\r\n<ul>\r\n<li>Detects phenylpyruvate in urine.</li>\r\n<li>Produces a <strong>green</strong></li>\r\n<li>Less reliable and is now largely replaced by <strong>tandem mass spectrometry</strong> in many countries.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Timing</strong>:\r\n<ul>\r\n<li>Phenylalanine elevation in blood may not be detectable until <strong>3-4 days postpartum</strong>.</li>\r\n<li>False positives can occur in <strong>premature infants</strong> due to immature liver enzyme systems.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Explanation of Other Options:</strong></p>\r\n<p><strong>Benedict test (Option A):</strong> Detects reducing sugars, not specific for phenylalanine or phenylpyruvate. Used in conditions like galactosemia or alkaptonuria.</p>\r\n<p><strong>FIGLU test (Option C): </strong>Used for diagnosing <strong>folic acid deficiency</strong> by measuring <strong>formiminoglutamic acid</strong> in urine after a histidine load.</p>\r\n<p><strong>Turbidometry (Option D): </strong>A nonspecific technique used in various clinical assays; not the traditional test for PKU.</p>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>The FeCl<sub>3</sub> test</strong> is the classical screening method for detecting <strong>phenylpyruvate in urine</strong> in suspected <strong>PKU</strong></li>\r\n<li>Modern screening programs prefer <strong>tandem mass spectrometry</strong> for accuracy.</li>\r\n</ul>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosine Transaminase</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Fumaryl Acetoacetate Hydrolase</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">4-Hydroxy Phenylpyruvate Hydroxylase</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosine aminotransferase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following metabolic defects is seen in Type I Tyrosinemia?</span></p>",
      "unique_key": "DT1211371",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211371,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Type I tyrosinemia (also called <strong>tyrosinosis</strong>) is caused by a <strong>deficiency of fumarylacetoacetate hydrolase</strong>, which leads to the accumulation of toxic metabolites resulting in liver failure, renal dysfunction, and a risk of hepatocellular carcinoma.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508115f94325a-0c03-4faa-bc02-dce312e7d505.png\">\n<ul>\n<li><strong>Tyrosine degradation pathway</strong>:<br /> Tyrosine &rarr; p-Hydroxyphenylpyruvate &rarr; Homogentisate &rarr; Maleylacetoacetate &rarr; Fumarylacetoacetate &rarr; Fumarate + Acetoacetate</li>\n<li><strong>Type I Tyrosinemia</strong>:\n<ul>\n<li>Enzyme defect: <strong>Fumarylacetoacetate hydrolase (FAH)</strong></li>\n<li>Accumulation of <strong>fumarylacetoacetate</strong> and <strong>succinylacetone</strong> (toxic)</li>\n<li>Clinical features: Liver failure, renal tubular dysfunction, cabbage-like odour</li>\n<li>Treatment: <strong>Diet low in tyrosine and phenylalanine</strong>, NTBC (nitisinone)</li>\n</ul>\n</li>\n<li>Untreated acute and chronic tyrosinosis leads to death from  <strong>liver failure</strong>. Therapy employs a diet low in tyrosine and phenylalanine.</li>\n</ul>\n<p><strong>Explanation of Other Options:</strong></p>\n<p><strong>Tyrosine Transaminase (Option A): </strong>Alternate name for Tyrosine aminotransferase, which is defective in <strong>Type II tyrosinemia</strong>. Converts tyrosine to p-hydroxyphenylpyruvate.</p>\n<p><strong>4-Hydroxyphenylpyruvate Hydroxylase (Option C): </strong>Defective in <strong>neonatal tyrosinemia</strong>. Converts p-hydroxyphenylpyruvate to homogentisate.</p>\n<p><strong>Tyrosine Aminotransferase (Option D): </strong>Another name for <strong>Tyrosine transaminase</strong>; defective in <strong>Type II tyrosinemia</strong>. First step in tyrosine degradation.</p>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Type I tyrosinemia is due to <strong>fumarylacetoacetate hydrolase deficiency</strong> and can lead to <strong>fatal liver failure</strong> without early intervention.<br /> </li>\n</ul>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Fumarate</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetyl-CoA</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxaloacetate</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The terminal products of Phenylalanine metabolism are all except:</span></p>",
      "unique_key": "DT1211373",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211373,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Phenylalanine metabolism leads to the formation of fumarate, acetate, and acetyl-CoA. <strong>Oxaloacetate is not derived from phenylalanine</strong>; hence, it is the correct answer.</p>\n<ul>\n<li>Phenylalanine is first converted to tyrosine.</li>\n<li>Tyrosine undergoes multiple enzymatic steps to form homogentisate, which is further broken down into maleylacetoacetate and fumarylacetoacetate.</li>\n<li>Fumarylacetoacetate splits into:\n<ul>\n<li><strong>Fumarate</strong> &rarr; Glucogenic <strong>(Option A ruled out)</strong></li>\n<li><strong>Acetoacetate</strong> &rarr; Ketogenic</li>\n</ul>\n</li>\n<li>Acetoacetate gives rise to:\n<ul>\n<li><strong>Acetyl-CoA (Option B ruled out)</strong></li>\n<li><strong>Acetate (Option D ruled out)</strong></li>\n</ul>\n</li>\n</ul>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosinase</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Tyrosine hydroxylase</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine hydroxylase</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Homogentisate oxidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Enzyme deficiency in albinism is:</span></p>",
      "unique_key": "DT1211374",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211374,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Tyrosinase is the key enzyme required for melanin biosynthesis; its deficiency leads to albinism.</p>\n<ul>\n<li>Albinism is an autosomal recessive disorder characterised by defective melanin production.</li>\n<li>Tyrosinase catalyses the initial steps in melanin synthesis, including the conversion of tyrosine to DOPA and subsequently to dopaquinone.</li>\n<li>In albinism, tyrosinase activity is either absent or significantly reduced, impairing melanin formation.</li>\n<li>Clinical manifestations include:\n<ul>\n<li>Hypopigmented skin, hair, and eyes.</li>\n<li>Increased sensitivity to UV radiation predisposes to melanomas.</li>\n<li>Ocular findings: photophobia, nystagmus, hypopigmented fundus, decreased visual acuity.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Tyrosine hydroxylase (Option B):</strong> Enzyme involved in catecholamine synthesis; not related to melanin production.</p>\n<p><strong>Phenylalanine hydroxylase (Option C):</strong> Converts phenylalanine to tyrosine; its deficiency causes phenylketonuria, not albinism.</p>\n<p><strong>Homogentisate oxidase (Option D):</strong> Deficiency causes alkaptonuria, which presents with dark urine and ochronosis.</p>\n<p><strong>Key Takeaways:</strong></p>\n<p>Tyrosinase is the essential enzyme for melanin production; its deficiency causes albinism.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081160a718de-f9b5-40ac-8e34-cbd29205180d.png\">",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylacetate</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylbutazone</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylacetylglutamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mousy body odour in PKU is due to:</span></p>",
      "unique_key": "DT1211376",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211376,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>The characteristic \"mousy\" or \"musty\" body odour in phenylketonuria (PKU) is due to the accumulation and excretion of phenylacetate, a byproduct of phenylalanine metabolism.</p>\n<ul>\n<li>Phenylketonuria is caused by a deficiency of <strong>phenylalanine hydroxylase</strong>, leading to the accumulation of phenylalanine.</li>\n<li>In the absence of this enzyme, <strong>phenylalanine</strong> is transaminated to <strong>phenylpyruvate</strong>.</li>\n<li>Phenylpyruvate is then metabolised into <strong>phenylacetate</strong> and <strong>phenyllactate</strong>.</li>\n<li><strong>Phenylacetate</strong> is responsible for the <strong>mousy/musty body odour</strong> observed in PKU patients.</li>\n<li>Excess phenylalanine and its derivatives are neurotoxic and cause irreversible cognitive impairment if untreated.</li>\n<li>Clinical Manifestations of Phenylketonuria (PKU) -\n<ul>\n<li>The affected infant is normal, at Profound<strong>mental retardation</strong>develops gradually if the infant remains untreated. Cognitive delay may not be evident for the 1st few months.</li>\n<li>Some may have a <strong>seborrheic or eczematoid rash</strong>, which is usually mild and disappears as the child grows older.</li>\n<li>These children have an <strong>unpleasant odour of phenylacetic</strong><strong>acid</strong>, which has been described as <strong>musty or mousey</strong>.</li>\n</ul>\n</li>\n<li>Early diagnosis and dietary restriction of phenylalanine can prevent neurological damage.<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/2025081191746a23-9075-47b5-aa6c-5f02fcf60ef0.png\"></li>\n</ul>\n<p><strong>Explanation of Other Options: </strong></p>\n<p><strong>Phenylalanine (Option A):</strong> Aromatic essential amino acid; substrate that accumulates in PKU but does not directly cause the mousy odour. Elevated phenylalanine is neurotoxic, but odour arises from its metabolic products.</p>\n<p><strong>Phenylbutazone (Option C):</strong> NSAID used for inflammatory conditions; not a metabolite of phenylalanine. Structurally unrelated to phenylalanine metabolism and not associated with PKU.</p>\n<p><strong>Phenylacetylglutamine (Option D):</strong> Conjugate excreted in urea cycle disorders and some hyperammonemic states; not characteristic of PKU. Typically seen in alternative nitrogen excretion pathways, not in phenylalanine metabolism.</p>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycine</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Tryptophan</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenyalalanine</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Lysine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following amino acid can be converted into a vitamin?\t</span></p>",
      "unique_key": "DT1211377",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211377,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\r\n<p>Tryptophan serves as a precursor for the synthesis of niacin (vitamin B<sub>3</sub>) in the human body through the kynurenine pathway.</p>\r\n<ul>\r\n<li>Approximately 60 mg of tryptophan yields 1 mg of niacin.</li>\r\n<li>This conversion is important in preventing pellagra in conditions of low dietary niacin.</li>\r\n<li>The pathway involves several enzymes and cofactors such as PLP (pyridoxal phosphate), iron, and FAD.</li>\r\n<li>Impairment in this conversion can occur due to deficiency of vitamin B<sub>6</sub>, iron, or riboflavin, or due to genetic disorders like Hartnup disease or carcinoid syndrome.</li>\r\n<li>Niacin and tryptophan are interdependent in maintaining adequate NAD<sup>+</sup> synthesis for energy metabolism.</li>\r\n<li>The tryptophan-to-niacin pathway also explains the occurrence of pellagra-like symptoms in vitamin B<sub>6</sub> deficiency.</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/20250811FZOKi.png\">",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Alanine\t</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspartate</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamate</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Glyoxylate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">: Which of the following would not act as a source of glycine by transamination?</span></p>",
      "unique_key": "DT1211386",
      "question_audio": null,
      "question_video": null,
      "map_id": 1211386,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Explanation:</strong></p>\n<p>Aspartate does not serve as a substrate in transamination reactions to form glycine. Glycine is formed by transamination reactions involving <strong>glyoxylate</strong>, <strong>glutamate</strong>, or <strong>alanine</strong>, not aspartate.</p>\n<ul>\n<li>Glycine can be synthesised by transamination of glyoxylate using either glutamate or alanine as the amino group donor.</li>\n<li>Other important sources of glycine include <strong>serine</strong> (via serine hydroxymethyltransferase) and <strong>choline</strong> (through several oxidation and demethylation steps).</li>\n</ul>\n<p><strong>Pathways of Glycine Synthesis:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGUPDATEDMCQ/202508119472adba-e940-4096-aa32-d62a7aedcac1.png\">\n<p><strong>Explanation of other options:</strong></p>\n<p><strong>Alanine (Option A):</strong> The Amino group from alanine can be transferred to glyoxylate to form glycine via alanine-glyoxylate aminotransferase.</p>\n<p><strong>Glutamate (Option C):</strong> Major amino group donor in transamination; donates amino group to glyoxylate, forming glycine.</p>\n<p><strong>Glyoxylate (Option D):</strong> Key keto acid that accepts amino groups to generate glycine; highly active in hepatic metabolism.</p>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}